U.S. Diagnostic, Steel Partners sign stock deal

Article

Radiology services firm U.S. Diagnostic has signed an agreement with Steel Partners II that allows Steel Partners to purchase up to 45% of U.S. Diagnostic’s voting stock without prior board approval. Steel Partners already owns approximately 15% of

Radiology services firm U.S. Diagnostic has signed an agreement with Steel Partners II that allows Steel Partners to purchase up to 45% of U.S. Diagnostic’s voting stock without prior board approval. Steel Partners already owns approximately 15% of U.S. Diagnostic’s stock.

The move comes as West Palm Beach, FL-based U.S. Diagnostic seeks to bolster its business. In the first three quarters of 1999, the company sold its underperforming facilities in Texas (SCAN 3/3/99) and fell from its first place position in the imaging center market to third, according to a report by SMG Marketing Group of Chicago (SCAN 1/19/00).

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.